Strengths of antigen rapid test: FAST & EASY (Compared with PCR test) People could RAPIDLY & EASILY be tested as a prerequisite to school attendance, work, or travel. FAST --PCR test - the swab test looks for viral RNA - may take days to perform. --Antigen test might take only 15-30 minutes to complete. EASY --PCR test swabs must be sent to laboratory to be performed by experienced technicians, it requires expensive and specialized equipment and can take days to get result. -- Antigen test can be run in an office or at home in about 15-30 minutes. The sampling process is FAST & EASY and requires very little expertise. Similar tests are done routinely in clinics for influenza all the time.
10,000 Rapid Antigen Test 500 Boxes 20 Test Per Box CE CERTIFICATION
[CONTENTS] (25) Test Kits (25) Individual Test Kits (25) Serum Pipets (1) Instruction For Use SENSITIVITY 100% | SPECIFICITY 97.3%
Rapid Antibody kit used for testing to detect the neutralized Antibodies in Patrons.
Covid19 Antigen testing kit is used for test patrons on Covid19 symptoms.
For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .
Lateral flow assay No equipment required Rapid results within 10 minutes Minimally invasive specimen collection (nasopharyngeal swabs) POC setting (i.e. in patient care settings) by medical professionals Detects SARS-CoV-2 nucleocapsid protein antigen with ultra high performance Identify acute infection wit 88.4% sensitive and 100% specificity 20 test/box 20 test devices 20 assay buffer 20 extraction vials and caps 20 specifimen collection swabs 1 positive and 1 negative control swabs 1 instructions for use
FDA EUA
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
Catalog Number: HSN01 Type: Point of Care Test Technical Details: Rapid antibody test kit made with blood sample Sample Types: Blood Plasma Sensitivity Rate: Sensitivity: 97%, Specifity: 97% Contents: Lancet, Pipette, Silica Gel, Alcohol Swab, Test cassette Number of Kits in a Box: 15 tests Storage Condition: Room Temperature Shipping Type: Shipping storage condition Room temperature Analysis Time: 15 Min < In short: In the IgG or IgM test line area, it reacts with locally bound anti-human IgG or IgM, respectively and forms a colored line. If sample does not contain any COVID-19 antibodies, a colored line showing a negative result will not appear in any of the Test Line Areas. As a positive check for the correct performance of the tape's procedure and operation, a colored line should always be appearing in the Control Line Area. If Control Line area is empty, then the test is invalid.
Catalog Number: FRT01 Type: FAMEX Coronavirus (2019-nCoV)-Antigentest Technical: Rapid Antigen Test Kit Specimen Types: Nasal Swab Claim: Sensitivity .7 Specifity Contents: Swab, Test Cassette, Specimen Tube, Medical Waste Bag,Silica Gel Number of Test: Disposable Storage: 2C 30 C Shipment Type: 2�°C â?? 30�°C Analysis Time: 15 Minutes Shortly: This kit is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein in nasal swab as an aid in the scientific research of primary and secondary COVID- 19 infections.Packaging, package leaflet and manual customized for various markets.
Antigen Rapid Tests for COVID-19 1. mLab mscreen Corona Antigen Test - Simple nasal swap or nasopharyngeal swab / 2. Laihe Novel - Nasopharyngeal swab / 3. Nal von minden dedico plus - Simple nasal swap or nasopharyngeal swab / 4. Joysbio Saliva Rapid Test Kit - Saliva Test Kit CE IVD certified, in stock in Germany, min. 10000 pcs, from EUR 4.99, free delivery within Germany
Laihe / Novel Corona Antigen Test Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Joysbio Saliva Rapid Test Kit - Saliva Test Kit for public use / under 30 minutes / Sensitivity 95.10% / TCID50 320 / CE IVD marked for public use / In stock in Germany
mLab / m-screen Corona Antigen Test Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
COVID-19 (2019-nCoV) Coronavirus IgG/IgM Rapid Test Kit Principle: based on Colloidal Gold Method, to detect COVID-19 IgG/IgM Antibody in serum, plasma, whole blood qualitatively. Easy to operate, results can be obtained in 15 minutes. Component: 25 tests cassttes/ 25 dropper/ 25 tubes of dilution buffer/25 Alcohol pad/ 25 Lancet/ 1 manual Certificate: CE, ISO13485, ISO9001
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
ANTIGEN RAPID TEST Price 6.5 EUR + VAT We send a POL after receiving the LOI. We deliver in Europe only. Only for Hospitals. More information? The new VivaDiag SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab,oropharyngeal swab or nasopharyngeal swab specimen. The test is for in vitro diagnostic use only. Special features: For nasal or throat swab samples CE marked Professional Use Only High Sensitivity Short Turnout Time High Specificity Test Principle: Colloidal gold Sample Type: Nasal swab, oropharyngeal swab or nasopharyngeal swab Sample Volume: 60 L Test Time: 15 min
Covid-19 - Antigen - Schnelltests
